Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism

Ridker, Paul M, Goldhaber, Samuel Z., Danielson, Ellie, Rosenberg, Yves, Eby, Charles S., Deitcher, Steven R., Cushman, Mary, Moll, Stephan, Kessler, Craig M., Elliott, C. Gregory, Paulson, Rolf, Wong, Turnly, Bauer, Kenneth A., Schwartz, Bruce A., Miletich, Joseph P., Bounameaux, Henri, Glynn, Robert J.·2003·New England Journal of Medicine
DOI 10.1056/nejmoa035029

Cited by (807)

Items 101–200 of 807

  1. Duration of Anticoagulation Following Venous Thromboembolism: A Meta-analysis
    Ost, David, Tepper, Josh, Mihara, Hanako, Lander, Owen, Heinzer, Raphael, Fein, Alan · 2005 · JAMA
  2. Recommendations on Testing for Thrombophilia in Venous Thromboembolic Disease: a French Consensus Guideline
    Gilles Pernod, Christine Biron‐Andréani, Pierre‐Emmanuel Morange, F Boehlen, J. Constans, Françis Couturaud, Ludovic O. Drouet, Brigitte Jude, Thomas Lecompte, Grégoire Le Gal et al. · 2009 · Journal des Maladies Vasculaires
  3. Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum
    David A. Garcia, Daniel M. Witt, Elaine M. Hylek, Ann K. Wittkowsky, Edith A. Nutescu, Alan K. Jacobson, Stephan Moll, Geno J. Merli, Mark Andrew Crowther, Laura E. Earl et al. · 2008 · Annals of Pharmacotherapy
  4. EDUC’AVK: Reduction of Oral Anticoagulant-related Adverse Events After Patient Education: A Prospective Multicenter Open Randomized Study
    Gilles Pernod, José Labarère, J Yver, Bernadette Satger, Benoît Allenet, Touffek Berremili, Michèle Fontaine, Guy Franco, Jean‐Luc Bosson · 2008 · Journal of General Internal Medicine
  5. Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based
    Marcel M Levi, G. Kees Hovingh, Suzanne C. Cannegieter, M. Vermeulen, Harry Roger Buller, Frits Richard Rosendaal · 2008 · Blood
  6. Invasive Approaches to Treatment of Venous Thromboembolism
    Peter Augustinos, Kenneth Ouriel · 2004 · Circulation
  7. Acute Pulmonary Embolism
    Gregory Piazza, Samuel Zachary Goldhaber · 2006 · Circulation
  8. Patients' perspectives on taking warfarin: qualitative study in family practice
    Guilherme Coelho Dantas, Barbara V Thompson, Judith Manson, C. Shawn Tracy, Ross E. G. Upshur · 2004 · BMC Family Practice
  9. Genetic Testing for Cardiovascular Disease Susceptibility: A Useful Clinical Management Tool or Possible Misinformation?
    Steve Eric Humphries, Paul M. Ridker, Philippa J. Talmud · 2004 · Arteriosclerosis Thrombosis and Vascular Biology
  10. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism
    Alfonso, Ana, Jiménez, David, Capitán, Carmen Fernández, Prandoni, Paolo, Wells, Philip S., Vidal, Gemma, Barillari, Giovanni, Monreal, Manuel, Lecumberri, Ramón, and the RIETE Investigators · 2013 · Thrombosis and Haemostasis
  11. Incidence of arterial cardiovascular events after venous thromboembolism: a systematic review and a meta-analysis
    Cecilia Becattini, Maria Cristina Vedovati, Walter Ageno, Francesco Dentali, Giancarlo Agnelli · 2010 · Journal of Thrombosis and Haemostasis
  12. A Polymorphism in the VKORC1 Regulator Calumenin Predicts Higher Warfarin Dose Requirements in African Americans
    Deepak Voora, Daniel C. Koboldt, C R King, Petra A. Lenzini, Charles S. Eby, Rhonda Porche-Sorbet, Elena Deych, Mark W. Crankshaw, Paul E. Milligan, Howard L. McLeod et al. · 2010 · Clinical Pharmacology & Therapeutics
  13. Mortality risk associated with venous thromboembolism: a systematic review and Bayesian meta-analysis
    Nicholas D. Klemen, Paul Lawrence Feingold, Barry Hashimoto, Melinda Wang, Svetlana Kleyman, Alexandria L. Brackett, Cary Philip Gross, Kevin Y. Pei · 2020 · The Lancet Haematology
  14. Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture*
    Gordon D O Lowe · 2006 · British Journal of Haematology
  15. How I treat the antiphospholipid syndrome
    Bill Giannakopoulos, Steven A. Krilis · 2009 · Blood
  16. D‐dimer, factor VIII coagulant activity, low‐intensity warfarin and the risk of recurrent venous thromboembolism
    S. SHRIVASTAVA, Paul M. Ridker, Robert J. Glynn, Samuel Zachary Goldhaber, Stephan Moll, Henri Bounameaux, Kenneth Alan Bauer, Craig M. Kessler, Mary Cushman · 2006 · Journal of Thrombosis and Haemostasis
  17. Laboratory Investigation of Thrombophilia: The Good, the Bad, and the Ugly
    Emmanuel J. Favaloro, David McDonald, Giuseppe Lippi · 2009 · Seminars in Thrombosis and Hemostasis
  18. Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation
    Nikolaus Sarafoff, Gjin Ndrepepa, Julinda Mehilli, K. Dörrler, Stefanie Schulz, Raisuke Iijima, Robert A. Byrne, Albert Schömig, Adnan Kastrati · 2008 · Journal of Internal Medicine
  19. Hormonal factors and risk of recurrent venous thrombosis: the Prevention of Recurrent Venous Thromboembolism trial
    Mary Cushman, Robert J. Glynn, Samuel Zachary Goldhaber, Stephan Moll, Kenneth Alan Bauer, Steven R. Deitcher, S. SHRIVASTAVA, Paul M. Ridker · 2006 · Journal of Thrombosis and Haemostasis
  20. Treatment of venous thromboembolism
    Harry Roger Buller, Maaike Söhne, Saskia Middeldorp · 2005 · Journal of Thrombosis and Haemostasis
  21. Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow‐up study
    Jasmijn F. Timp, Willem M. Lijfering, Linda E. Flinterman, Astrid van Hylckama Vlieg, Saskia le Cessie, Frits Richard Rosendaal, Suzanne C. Cannegieter · 2015 · Journal of Thrombosis and Haemostasis
  22. Clinical Characteristics and Long-term Follow-up of Patients With Renal Vein Thrombosis
    Waldemar E. Wysokiński, Izabela Gosk−Bierska, Eddie L. Greene, Diane E. Grill, Heather J. Wiste, Robert D. McBane · 2008 · American Journal of Kidney Diseases
  23. Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study
    John A. Heit, Brian D. Lahr, Tanya M. Petterson, Kent R. Bailey, Aneel A. Ashrani, L. Joseph Melton · 2011 · Blood
  24. Protein C and protein S deficiency - practical diagnostic issues.
    Ewa Wypasek, Anetta Undas · 2013 · PubMed
  25. Oral direct thrombin inhibitors in clinical development
    D. Gustafsson · 2003 · Journal of Internal Medicine
  26. Performance of Commercial Platforms for Rapid Genotyping of Polymorphisms Affecting Warfarin Dose
    Cristi R. King, Rhonda Porche-Sorbet, Brian F. Gage, Paul M. Ridker, Yannick Renaud, Michael S. Phillips, Charles Eby · 2008 · American Journal of Clinical Pathology
  27. Administrative Claims Analysis of the Relationship Between Warfarin Use and Risk of Hemorrhage Including Drug-Drug and Drug-Disease Interactions
    Kui Zhang, Christopher Young, Jan E Berger · 2006 · Journal of Managed Care Pharmacy
  28. Prevention, Diagnostics and Treatment of Deep Vein Thrombosis. Russian Experts Consensus
    E.I. Seliverstov, Kirill Victorovich Lobastov, Е.А. Ilyukhin, Tatiana V. Apkhanova, Rustem V. Akhmetzyanov, Il'dar Fuatovich Akhtyamov, Victor Barinov, A.S. Bakhmetiev, Mikhail V. Belov, Бобров Сергей Александрович et al. · 2023 · Journal of Venous Disorders
  29. Consenso nacional sobre el diagnóstico, estratificación de riesgo y tratamiento de los pacientes con tromboembolia pulmonar
    Fernando Uresandi, Manuel Monréal, Ferrán García-Bragado, Pere Domenech, Ramón Lecumberri, Pilar Escribano, José Luis Zamorano, Sònia Jiménez, Pedro Ruiz‐Artacho, Francisco Lozano et al. · 2013 · Archivos de Bronconeumología
  30. Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy
    Kaitlyn Shaw, Ursula Amstutz, Richard B. Kim, Lawrence J. Lesko, Jacques Turgeon, Véronique Michaud, Soomi Hwang, Shinya Ito, Colin J. Ross, Bruce Carleton · 2015 · Therapeutic Drug Monitoring
  31. Inherited Risk Factors for Venous Thrombosis
    Mary Cushman · 2005 · Hematology
  32. Sex Differences in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
    Ángeles Blanco-Molina, Iolanda Enea, Telma Gadelha, Antonella Tufano, Alessandra Bura-Rivière, Pierpaolo Di Micco, Henri Bounameaux, José González, Jaume Villalta, Manuel Monréal · 2014 · Medicine
  33. GENETIC TESTING IN PRIMARY CARE
    Wylie Burke · 2004 · Annual Review of Genomics and Human Genetics
  34. Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy
    N. S. FERDER, C.S. EBY, Elena Birman-Deych, Jenine K. Harris, Paul M. Ridker, Paul E. Milligan, Samuel Zachary Goldhaber, C.R. KING, Tusar Kanti Giri, Howard L. McLeod et al. · 2009 · Journal of Thrombosis and Haemostasis
  35. Effect of Low-Dose Aspirin on the Occurrence of Venous Thromboembolism
    Robert J. Glynn, Paul M. Ridker, Samuel Zachary Goldhaber, Julie E. Buring · 2007 · Annals of Internal Medicine
  36. The diagnosis and treatment of venous thromboembolism
    Wells, Philip, Anderson, David · 2013 · Hematology
  37. Thrombotic Disorders: Diagnosis and Treatment
    Andrew I. Schafer, Mark N. Levine, Barbara A. Konkle, Clive Kearon · 2003 · Hematology
  38. Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design
    E J Do, Petra A. Lenzini, Charles S. Eby, Anne R. Bass, Gwendolyn A. McMillin, Scott M. Stevens, Scott C. Woller, Robert C. Pendleton, Jeffrey L. Anderson, P Proctor et al. · 2011 · The Pharmacogenomics Journal
  39. Treatment of DVT: how long is enough and how do you predict recurrence
    Giancarlo Agnelli, Cecilia Becattini · 2007 · Journal of Thrombosis and Thrombolysis
  40. Pulmonary Embolism and Atrial Fibrillation: Two Sides of the Same Coin? A Systematic Review
    Maen D. Abou Ziki, Gregory Y.H. Lip, Behnood Bikdeli · 2017 · Seminars in Thrombosis and Hemostasis
  41. A systematic review of design for X techniques from 1980 to 2018: concepts, applications, and perspectives
    Abla Chaouni Benabdellah, Imane Bouhaddou, Asmaa Benghabrit, Oussama Benghabrit · 2019 · The International Journal of Advanced Manufacturing Technology
  42. Cancer and Thrombosis: Mechanisms and Treatment
    Steven R. Deitcher · 2003 · Journal of Thrombosis and Thrombolysis
  43. Periprocedural Anticoagulation Management of Patients With Venous Thromboembolism
    Robert D. McBane, Waldemar E. Wysokiński, Paul R. Daniels, Scott C. Litin, Joshua P. Slusser, David O. Hodge, Nicole F. Dowling, John A. Heit · 2010 · Arteriosclerosis Thrombosis and Vascular Biology
  44. Acute Pulmonary Embolism
    Paul D. Stein, Fadi Matta · 2010 · Current Problems in Cardiology
  45. Opportunity Cost of Funding Drugs for Rare Diseases
    Doug Coyle, Matthew C. Cheung, Gerald A. Evans · 2014 · Medical Decision Making
  46. Complement C3 and High Risk of Venous Thromboembolism: 80517 Individuals from the Copenhagen General Population Study
    Ina Nørgaard, Sune Fallgaard Nielsen, Børge Grønne Nordestgaard · 2016 · Clinical Chemistry
  47. Hypercoagulable States
    Julia A. M. Anderson, Jeffrey Ian Weitz · 2011 · Critical Care Clinics
  48. The Nonsteroidal Effects of Diethylstilbestrol: The Rationale for Androgen Deprivation Therapy Without Estrogen Deprivation in the Treatment of Prostate Cancer
    Douglas S. Scherr, W. Reid Pitts · 2003 · The Journal of Urology
  49. A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES)
    Anabel Franco‐Moreno, María José García Navarro, J. Ortiz Sánchez, R.M. Martín Díaz, Elena Madroñal Cerezo, C. L. De Ancos Aracil, Noemí Cabello Clotet, Isabel Perales Fraile, Sobrino García, C. Montero Hernández et al. · 2016 · European Journal of Internal Medicine
  50. Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis
    Alexander Thomas Cohen, M. Hamilton, Alex Bird, S.A. Mitchell, Sisi Li, Ruslan V. Horblyuk, Sarah Batson · 2016 · PLoS ONE
  51. Risk of gastrointestinal bleeding during anticoagulant treatment
    Aitor Lanas-Gimeno, Angel Lanas · 2017 · Expert Opinion on Drug Safety
  52. Inherited Thrombophilia
    Massimo Franchini, Dino Veneri, Gian Luca Salvagno, Franco Manzato, Giuseppe Lippi · 2006 · Critical Reviews in Clinical Laboratory Sciences
  53. Management of Venous Thromboembolism: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians
    Vincenza T. Snow, Amir Qaseem, Patricia P. Barry, E. Rodney Hornbake, Jonathan E Rodnick, Timothy J. Tobolic, Belinda K. Ireland, Jodi B Segal, Eric B Bass, Kevin B. Weiss et al. · 2007 · The Annals of Family Medicine
  54. New Anticoagulants for Treatment of Venous Thromboembolism
    Jeffrey Ian Weitz · 2004 · Circulation
  55. Time-dependent hardening of blood clots quantitatively measured in vivo with shear-wave ultrasound imaging in a rabbit model of venous thrombosis
    Etienne Mfoumou, Julien Tripette A, Mark D. Blostein, Guy Cloutier · 2013 · Thrombosis Research
  56. A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families
    Willem M. Lijfering, Nic J.G.M. Veeger, Saskia Middeldorp, Karly Hamulyák, Martin H. Prins, Harry Roger Buller, Jan van der Meer · 2009 · Blood
  57. Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis
    Juan Francisco Sánchez Muñoz-Torrero, Henri Bounameaux, José María Pedrajas, Alicia Lorenzo, Silvino Rubio, Clive Kearon, Luis Manuel Hernández, Manuel Monréal · 2011 · Journal of Vascular Surgery
  58. Guía para el diagnóstico, tratamiento y seguimiento de la tromboembolia pulmonar
    Fernando Uresandi, José Blanquer, Francisco Conget, Miguel Ángel de Gregorio, José Luís Lobo, Remedios Otero, Esteban Pérez Rodríguez, Manuel Monréal, Pilar Morales · 2004 · Archivos de Bronconeumología
  59. Marburg I polymorphism of factor VII–activating protease is associated with idiopathic venous thromboembolism
    Berthold Hoppe, Farzaneh Tolou, H. Radtke, H. Kiesewetter, Thomas Dörner, Abdulgabar Salama · 2004 · Blood
  60. Gamma-glutamyl carboxylase and its influence on warfarin dose
    Cristi R. King, Elena Deych, Paul E. Milligan, Charles Eby, Petra A. Lenzini, Gloria R. Grice, Rhonda Porche-Sorbet, Paul M. Ridker, Brian F. Gage · 2010 · Thrombosis and Haemostasis
  61. Venous thromboembolism in the elderly: A narrative review
    Tobias Tritschler, Drahomir Aujesky · 2017 · Thrombosis Research
  62. Recommendations from the EGAPP Working Group: Routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members
    Alfred O. Berg, Jeffrey R. Botkin, Ned Calonge, Doug E Campos-Outcalt, James E. Haddow, Maxine Hayes, Celia I. Kaye, Roger D. Klein, Kenneth Offit, Stephen G. Pauker et al. · 2011 · Genetics in Medicine
  63. Prophylaxis and treatment of deep vein thrombosis in general surgery
    Carsten N. Gutt, Traian Oniu, F. Wolkener, Ari Mehrabi, Shilu Mistry, Markus Wolfgang Büchler · 2005 · The American Journal of Surgery
  64. Submassive Pulmonary Embolism
    Gregory Piazza · 2013 · JAMA
  65. Thromboembolic Therapies in Dogs and Cats: An Evidence-Based Approach
    Kari V. Lunsford, Andrew J. Mackin · 2007 · Veterinary Clinics of North America Small Animal Practice
  66. Whole blood gene expression analyses in patients with single versus recurrent venous thromboembolism
    DEBORAH A. LEWIS, Gregg J. Stashenko, Olga Meltem Akay, Lulit I. Price, Kouros Owzar, Geoffrey S. Ginsburg, Jen‐Tsan Chi, Thomas L. Ortel · 2011 · Thrombosis Research
  67. Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism
    Rupert Martin Bauersachs, Jan Beyer‐Westendorf, Henri Bounameaux, Timothy Brighton, Alexander T. Cohen, Bruce L. Davidson, Gerlind Holberg, Ajay K. Kakkar, Anthonie W.A. Lensing, Martin H. Prins et al. · 2015 · Thrombosis and Haemostasis
  68. Diretrizes Brasileiras de Antiagregantes Plaquetários e Anticoagulantes em Cardiologia
    A M Lorga Filho, AD Azmus, AM Soeiro, AS Quadros, Álvaro Avezum, AC Marques, André Franci, ALL Manica, André Volschan, AAV de Paola et al. · 2013 · Arquivos Brasileiros de Cardiologia
  69. Activated Protein C Resistance and Factor V Leiden: A Review
    Adam Rosendorff, David M. Dorfman · 2007 · Archives of Pathology & Laboratory Medicine
  70. Oral anticoagulation therapy in children
    Mariana M. Bonduel · 2005 · Thrombosis Research
  71. A randomised control trial of patient self‐management of oral anticoagulation compared with patient self‐testing
    Chris Gardiner, Karen Williams, Ian Longair, Ian J. Mackie, Samuel J. Machin, Hannah Cohen · 2005 · British Journal of Haematology
  72. Acute Pulmonary Embolism
    Piotr S. Sobieszczyk, Michael C. Fishbein, Samuel Zachary Goldhaber · 2002 · Circulation
  73. Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis
    Faizan Ahmad Khan, Tobias Tritschler, Miriam Kimpton, Philip Stephen Wells, Clive Kearon, Jeffrey Ian Weitz, Harry Roger Buller, Gary E. Raskob, Walter Ageno, Françis Couturaud et al. · 2021 · Journal of Thrombosis and Haemostasis
  74. Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy
    Yong‐Joon Lee, Jin‐Kyu Park, Jae‐Sun Uhm, Jong‐Youn Kim, Hui‐Nam Pak, Moon‐Hyoung Lee, Jung‐Hoon Sung, Boyoung Joung · 2015 · International Journal of Cardiology
  75. Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study
    Grégoire Le Gal, Marc Carrier, M.J. Kovacs, Marisol T. Betancourt, S.R. Kahn, Philip S. Wells, David R. Anderson, Isabelle Chagnon, Susan Solymoss, M. CROWTHER et al. · 2011 · Journal of Thrombosis and Haemostasis
  76. Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism
    José Antonio Nieto, Rosario Solano, Natacha Trapero Iglesias, N. Ruiz‐Giménez, Carmen Fernández‐Capitán, Beatriz Valero, Gregorio Tiberio, Alessandra Bura-Rivière, Manuel Monréal · 2013 · Thrombosis Research
  77. Measuring Quality of Oral Anticoagulation Care: Extending Quality Measurement to a New Field
    Adam J. Rose, Dan R. Berlowitz, Susan M. Frayne, Elaine M. Hylek · 2009 · The Joint Commission Journal on Quality and Patient Safety
  78. Lipid lowering drugs and the risk of recurrent venous thromboembolism
    Aurélien Delluc, Cécile Tromeur, Emmanuelle Le Moigne, Emmanuel Nowak, Dominique Mottier, Grégoire Le Gal, Karine Lacut · 2012 · Thrombosis Research
  79. Reduction in Warfarin Adverse Events Requiring Patient Hospitalization After Implementation of a Pharmacist‐Managed Anticoagulation Service
    Christy Locke, Susan L. Ravnan, Rajul A. Patel, James A. Uchizono · 2005 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  80. Incidence of post-thrombotic syndrome and its association with various risk factors in a cohort of Spanish patients after one year of follow-up following acute deep venous thrombosis
    Manuel Labiós, Olga Portolés, Marisa Guillén, Dolores Corella, Francesc Francès, Marcial Martı́nez, Joaquín Gil, Carmen Sáiz, Francisco Gabriel · 2004 · Thrombosis and Haemostasis
  81. Usefulness of high‐sensitivity IL‐6 measurement for clinical characterization of patients with coronary artery disease
    Valter Lubrano, Franca Cocci, Débora Bignotto Rosane Battaglia, Angela Papa, Paolo Marraccini, Gian Carlo Zucchelli · 2005 · Journal of Clinical Laboratory Analysis
  82. Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: an observational study
    Sanjeev Kumar, Ananda Chapagain, Dorothea Nitsch, Muhammad Magdi Yaqoob · 2012 · BMC Nephrology
  83. Dyslipidemia, statins, and venous thromboembolism: a potential risk factor and a potential treatment
    Joel Geoffrey Ray · 2003 · Current Opinion in Pulmonary Medicine
  84. The Impact of Venous Thromboembolism on Risk of Death or Hemorrhage in Older Cancer Patients
    Cary Philip Gross, Deron H. Galusha, Harlan M. Krumholz · 2007 · Journal of General Internal Medicine
  85. Efficacy and Safety of New Oral Anticoagulants for Extended Treatment of Venous Thromboembolism: Systematic Review and Meta-Analyses of Randomized Controlled Trials
    Partha Sardar, Saurav Chatterjee, Debabrata Mukherjee · 2013 · Drugs
  86. Management of thrombophilia
    Kenneth Alan Bauer · 2003 · Journal of Thrombosis and Haemostasis
  87. Hemostasis and Thrombosis
    Richard Clinton Becker, Deepak Voora, Svati Hasmukh Shah · 2012 · Elsevier eBooks
  88. Intracranial and fatal bleeding according to indication for long‐term oral anticoagulant therapy
    Lori‐Ann Linkins, Martin James O'Donnell, J.A. Julian, Clive Kearon · 2010 · Journal of Thrombosis and Haemostasis
  89. Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients
    Mario Monaco, Luigi Di Tommaso, Giovanni Pinna, Stefano Lillo, Vincenzo Schiavone, Paolo Stassano · 2012 · Journal of Vascular Surgery
  90. Hypercoagulable States
    Julia A. M. Anderson, Jeffrey Ian Weitz · 2010 · Clinics in Chest Medicine
  91. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism
    Gema Díaz, Elena Marín, Rafael Vidal, Antonio Sueiro, Roger D. Yusen, David Jiménez · 2006 · Thrombosis and Haemostasis
  92. Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation
    Umberto Cucchini, Gentian Denas, Bruce Davidson, Filippo Marzot, Seena Padayattil Jose, Sabino Iliceto, Vittorio Pengo · 2010 · Thrombosis and Haemostasis
  93. The effect of levonorgestrel-releasing intrauterine device on menorrhagia in women taking anticoagulant medication after cardiac valve replacement
    Sevtap Kılıç, Beril Yüksel, Melike Doğanay, Haşmet Bardakçı, Filiz Akın Su, Özlem Uzunlar, Leyla Mollamahutoglu · 2009 · Contraception
  94. Long-Term Prospective Study of Recurrent Venous Thromboembolism in Patients Younger than 50 Years
    María José García-Fuster, María-José Forner, Conrado Fernández, Joaquín Gil, Amparo Vayá, Luis Maldonado · 2005 · Pathophysiology of Haemostasis and Thrombosis
  95. Thrombolytic Therapy and Mortality in Patients With Acute Pulmonary Embolism
    Said A. Ibrahim, Roslyn A. Stone, David Scott Obrosky, Ming Geng, Michael J. Fine, Drahomir Aujesky · 2008 · Archives of Internal Medicine
  96. Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism
    Adam Torbicki, Arnaud Perrier, Stavros Konstantinides, Giancarlo Agnelli, Nazzareno Galiè, Piotr Pruszczyk, Frank Michael Bengel, Adrian J B Brady, Daniel Ferreira, Uwe Janssens et al. · 2008 · Revista Española de Cardiología (English Edition)
  97. Recurrent Venous Thromboembolism: What Is the Risk and How to Prevent It
    Gualtiero Palareti · 2012 · Scientifica
  98. Endovascular Treatment of Peripheral Vascular Disease
    Suhail Q. Allaqaband, Romas J. Kirvaitis, Fuad Jan, TANVIR K. BAJWA · 2009 · Current Problems in Cardiology
  99. Hypercoagulability in Athletes
    Christopher D. Meyering, Thomas Howard · 2004 · Current Sports Medicine Reports
  100. Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis
    Pier Luigi Meroni, Marco Moia, Ronald H. W. M. Derksen, Anǵela Tincani, John A. McIntyre, Jozef Arnout, T Koike, J.C. Pietté, Munther A. Khamashta, Yehuda Shoenfeld · 2003 · Lupus